The world is ﬁghting the COVID-19 outbreak and health workers,
including inﬂammatory bowel diseases specialists, have been challenged to address
the speciﬁc clinical issues of their patients. We hereby summarize
the current literature in the management of inﬂammatory bowel disease
(IBD) patients during the COVID-19 pandemic era that support the
rearrangement of our IBD unit and the clinical advice provided
to our patients.